In cancer models, Trem-1 deficiency led to reduced tumor growth (melanoma, fibrosarcoma), less immunosuppressive activity of MDSCs and higher expression of PD-1 on CD8+T cells, pointing to a role in shaping the tumor immune microenvironment. This evidence concerns the gene TREM1 and cancer.